146 related articles for article (PubMed ID: 23456839)
1. The CD28/B7 pathway: a novel regulator of plasma cell function.
Njau MN; Jacob J
Adv Exp Med Biol; 2013; 785():67-75. PubMed ID: 23456839
[TBL] [Abstract][Full Text] [Related]
2. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
[TBL] [Abstract][Full Text] [Related]
3. CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection.
Cook CH; Chen L; Wen J; Zimmerman P; Zhang Y; Trgovcich J; Liu Y; Gao JX
Viral Immunol; 2009 Apr; 22(2):91-103. PubMed ID: 19326996
[TBL] [Abstract][Full Text] [Related]
4. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal and Streptococcal Superantigens Trigger B7/CD28 Costimulatory Receptor Engagement to Hyperinduce Inflammatory Cytokines.
Popugailo A; Rotfogel Z; Supper E; Hillman D; Kaempfer R
Front Immunol; 2019; 10():942. PubMed ID: 31114583
[TBL] [Abstract][Full Text] [Related]
7. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Fallarino F; Fields PE; Gajewski TF
J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
[TBL] [Abstract][Full Text] [Related]
8. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.
Zheng X; Gao JX; Chang X; Wang Y; Liu Y; Wen J; Zhang H; Zhang J; Liu Y; Zheng P
J Immunol; 2004 Aug; 173(4):2253-61. PubMed ID: 15294937
[TBL] [Abstract][Full Text] [Related]
9. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
Chang TT; Kuchroo VK; Sharpe AH
Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
[No Abstract] [Full Text] [Related]
10. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
12. Absence of B7-dependent responses in CD28-deficient mice.
Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
[TBL] [Abstract][Full Text] [Related]
13. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
[TBL] [Abstract][Full Text] [Related]
14. The interaction properties of costimulatory molecules revisited.
Collins AV; Brodie DW; Gilbert RJ; Iaboni A; Manso-Sancho R; Walse B; Stuart DI; van der Merwe PA; Davis SJ
Immunity; 2002 Aug; 17(2):201-10. PubMed ID: 12196291
[TBL] [Abstract][Full Text] [Related]
15. CD28/B7 costimulation: a review.
Greenfield EA; Nguyen KA; Kuchroo VK
Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
[TBL] [Abstract][Full Text] [Related]
16. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
17. Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase.
Li XL; Sluijter M; Doorduijn EM; Kale SP; McFerrin H; Liu YY; Li Y; Mottamal M; Yao X; Du F; Gu B; Hoang K; Nguyen YH; Taylor N; Stephens CR; van Hall T; Zhang QJ
PLoS One; 2014; 9(11):e108192. PubMed ID: 25383875
[TBL] [Abstract][Full Text] [Related]
18. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells.
Rozanski CH; Arens R; Carlson LM; Nair J; Boise LH; Chanan-Khan AA; Schoenberger SP; Lee KP
J Exp Med; 2011 Jul; 208(7):1435-46. PubMed ID: 21690252
[TBL] [Abstract][Full Text] [Related]
19. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman GJ; Long AJ; Iwai Y; Bourque K; Chernova T; Nishimura H; Fitz LJ; Malenkovich N; Okazaki T; Byrne MC; Horton HF; Fouser L; Carter L; Ling V; Bowman MR; Carreno BM; Collins M; Wood CR; Honjo T
J Exp Med; 2000 Oct; 192(7):1027-34. PubMed ID: 11015443
[TBL] [Abstract][Full Text] [Related]
20. A costimulation-initiated signaling pathway regulates NFATc1 transcription in T lymphocytes.
Nurieva RI; Chuvpilo S; Wieder ED; Elkon KB; Locksley R; Serfling E; Dong C
J Immunol; 2007 Jul; 179(2):1096-103. PubMed ID: 17617602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
